洞察市场格局
解锁药品研发情报

客服电话

400-9696-311
医药数据查询

2022年浙江新和成股份有限公司中报

报告时间

2022-06-30

股票代码

002001.SZ

报告类型

中报

货币类型

CNY

营业收入

8,215,039,277.03

营业毛利润

3,269,916,473.64

净利润

2,223,867,122.27

报告附件
详细报告内容
Zhejiang NHU Company Ltd. 2022 Semi-Annual Report August 2022 Section I Important Notes, Contents, and Definitions The Board of Directors and its members, Board of Supervisors and its members, and senior executives of the Company hereby guarantee that the information presented in this semi-annual report is authentic, accurate, complete and free of false records, misleading statements or material omissions, and they will bear individual and joint liabilities for such information. 胡柏藩 (Hu Baifan), the Company’s legal representative, 石观群 (Shi Guanqun), the officer in charge of accounting, and 王晓碧 (Wang Xiaobi), the head of accounting department hereby declare that they guarantee the financial statements in this semi-annual report are authentic, accurate and complete. All members of the Board of Directors have attended the meeting of the Board of Directors for deliberation of this semi-annual report. The future plan and other forward-looking information disclosed in this semi- annual report shall not be regarded as a commitment to investors. We kindly remind investors of all possible risks in investments. The Company will not distribute cash dividend, distribute bonus shares, or distribute shares from capital reserve during the current reporting period. This Semi-Annual Report is an English translation of the Chinese Semi-Annual Report. In case the English version does not conform to the Chinese version, the Chinese version prevails. Contents Section I Important Notes, Contents, and Definitions...... 1 Section II Company Profile and Key Financial Indicators...... 5 Section III Management Discussion and Analysis...... 9 Section IV Corporate Governance ...... 20 Section V Environmental and Social Responsibilities...... 22 Section VI Significant Events...... 27 Section VII Movements in Shares and Information about Shareholders...... 35 Section VIII Preferred Shares ...... 40 Section IX Bonds...... 41 Section X Financial Report ...... 42 DocumentsAvailable for Reference I. Financial statements signed and sealed by the Company’s legal representative, officer in charge of accounting, and head of accounting department; II. Original copy of all the Company's documents and announcements published on the newspapers designated by CSRC within the reporting period III. Other documents for reference. Definitions Abbreviations Refers to Contents of definitions The Company, NHU Refers to ZHEJIANG NHU CO., LTD. CSRC Refers to China Securities Regulatory Commission PPS Refers to Polyphenylene sulfide PPA Refers to Poly phthalamide VOC Refers to Volatile organic compound NH-acid Refers to Taurine F5 Refers to Vitamin B5 ARC Refers to Accelerating ratecalori meter NBC Refers to Azabicycles CLA Refers to Karon anhydride SNCR Refers to Selective non-catalytic reduction Section II Company Profile and Key Financial Indicators I. Company profile Stock abbreviation NHU Stock code 002001 Stock Exchange Shenzhen Stock Exchange Company Name in Chinese 浙江新和成股份有限公司 Company Abbreviation in 新和成 Chinese Company name in foreign ZHEJIANG NHU CO., LTD. language (if any) Company Abbreviation in NHU foreign language (if any) Legal representative Hu Baifan II. Contact information Items Board secretary Securities affairs representative Name Shi Guanqun 曾淑颖 (Zeng Shuying) Contact address No.418 Xinchang Dadao West Road, Xinchang, No.418 Xinchang Dadao West Road, Xinchang, Zhejiang, P.R.China Zhejiang, P.R.China Tel. +86 575 86017157 +86 575 86017157 Fax +86 575 86125377 +86 575 86125377 E-mail address sgq@cnhu.com 002001@cnhu.com III. Other Information 1. Company’s Contact Information Whether the Company’s registered address, office address, zip code, website and e-mail address has changed during the reporting period □ Applicable √ Not applicable The Company’s registered address, office address, zip code, website and e-mail address have not changed during the reporting period, which can be found in the 2021 Annual Report. 2. Information Disclosure and Location Whether information disclosure and location has changed during the reporting period □ Applicable √ Not applicable The name of the Company’s selected information disclosure newspaper, the URL of the website designated by the CSRC where the semi-annual report is posted, and the place where the Company’s semi-annual report is available have not changed during the reporting period, which can be found in the 2021 Annual Report. 3. Other relevant Information Whether other relecant information has changed during the reporting period □ Applicable √ Not applicable IV. Key accounting data and financial indicators Whether the Company needs to perform retroactive adjustment or restatement on financial data of prior years √ Yes □ No Reason for retroactive adjustment or restatement Accounting policy changes and other reasons Increase/ Decrease at the end of the current The Same Period of the Previous Year reporting period Items The Current compared with the same Reporting Period period of the previous year Before adjustment After adjustment[Note2] After adjustment Operating revenue (yuan) 8,215,039,277.03 7,254,221,638.01 7,340,124,310.11 11.92% Net profit attributable to shareholders of listed 2,213,877,419.25 2,408,499,133.50 2,426,979,148.42 -8.78% company (yuan) Net profit attributable to shareholders of listed company after deducting 2,094,055,949.62 2,279,454,655.63 2,279,438,579.04 -8.13% non-recurring profit or loss (yuan) Net cash flows from 1,242,456,738.20 2,271,157,481.77 2,289,637,496.69 -45.74% operating activities (yuan) Basic EPS (yuan/share) 0.72 0.78[Note1] 0.79 -8.86% Diluted EPS (yuan/share) 0.72 0.78[Note1] 0.79 -8.86% Weighted average ROE 9.55% 12.02% 11.87% Decreased by 2.32 percentage points Increase/Decrease at the end of the current Dec. 31, 2021 reporting period Items Jun. 30, 2022 compared with the end of the previous year Before adjustment After adjustment[Note2] After adjustment Total assets (yuan) 37,815,015,843.65 34,692,165,111.88 34,724,025,476.79 8.90% Net assets attributable to shareholders of listed 22,113,966,711.03 21,799,977,645.94 21,831,838,010.85 1.29% company (yuan) [Note1] After the implementation of the Company’s 2021 profit distribution plan, its share capital was increased from 2,578,394,760 shares to 3,090,907,356 shares. The above EPS of the comparative period was recalculated based on the adjusted share capital. [Note2] The company has implemented The Interpretation of Accounting Standards for Business Enterprises No. 15 since January 1, 2022. The interpretation requires that if the company sells the products or by-products produced before the fixed assets reach the expected serviceable state or during the research and development process, the income and cost related to the trial operation sales shall be accounted for separately and included in the current profit and loss, The net amount of the revenue from trial operation sales after offsetting the relevant costs shall not be used to offset the cost of fixed assets or R&D expenses. The company makes retroactive adjustment according to requirements. V. Differences in accounting dataunderChineseaccountingstandards and overseas accounting standards 1. Difference in net profit and net assets in financial statements disclosed respectively under IFRS Standards and Chinese accounting standards □ Applicable √ Not Applicable The Company has no difference in net profit or net assets in financial statements disclosed respectively under IFRS Standards and Chinese accounting standards. 2. Difference in net profit and net assets in financial statements disclosed respectively under overseas accou
相关报告
序号
名称
操作
01
【2022】浙江新和成股份有限公司年报报告
02
【2022】浙江新和成股份有限公司三季报报告
03
【2022】浙江新和成股份有限公司一季报报告
基于您的浏览,68%的用户还关注了【企业竞争格局】
获取更多浙江新和成股份有限公司竞争格局数据查看权限
立即前往摩熵医药企业版免费查询
示例数据
<END>
上市企业年报

最新企业动态资讯

摩熵医药企业版
50亿+条医药数据随时查
7天免费试用